Drug Search Results
Using advanced filters...
Advanced Search [+]

Sanfetrinem

Alternative Names: sanfetrinem
Latest Update: 2025-02-21
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: TASK Applied Science
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Sanfetrinem

Countries in Clinic: South Africa

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Tuberculosis, Pulmonary

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

TASK-009-SANF

P2

Completed

Tuberculosis, Pulmonary

2024-08-19

Recent News Events